On behalf of the User Authentication team....
Authentication has always played a central role in medical prescriptions for controlled substances, especially in preventing fraud and abuse. Today, Symantec Authentication helped improve that process even further for electronic prescriptions. We’re proud to announce that DrFirst, one of the country’s major providers of electronic prescription services, is using Symantec’s VeriSign Identity Protection (VIP) credentials in a landmark new product, EPCS Gold.
We’re excited for a number of reasons. First, we’re enabling the first e-prescription product that follows the Drug Enforcement Administration (DEA)’s rules for electronic prescriptions for controlled substances, which became effective in June 2010. To verify prescribers’ identities, these rules mandate those professionals use strong two-factor authentication that meets federal assurance requirements.
Enter VIP. Every time they log in, EPCS Gold users must provide their username, password and a six-digit security code generated by their Symantec VIP credential. This code changes with every log in, helping ensure that only authorized users possessing the credential can access the service, and access it securely every time.
Another reason we’re excited is that this the first joint technology offering anywhere that combines identity proofing and strong authentication. We worked closely with both DrFirst and Experian’s Precise IDSM platform, which vets applicants when they sign up for the service. This pairing of expert vetting with strong authentication ultimately means better patient care, as authorized prescribers can securely and quickly send prescriptions electronically, shortening patients’ wait times for their prescriptions.